Laurion Capital Management »

Urogen Pharma shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.8M 251k 15.00
2023-09-30 $5.3M 381k 14.01
2023-06-30 $3.8M 369k 10.35
2023-03-31 $3.5M 381k 9.24
2022-12-31 $3.4M 381k 8.87
2022-09-30 $3.2M 381k 8.32
2022-06-30 $3.1M 381k 8.19
2017-12-31 $1.8M 48k 37.20

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A Call Option (META)
Apple (AAPL)
Tesla Motors Call Option (TSLA)
Kenvue (KVUE)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Adobe Systems Incorporated Call Option (ADBE)
Alphabet Cap Stk Cl C Call Option (GOOG)
Bridgebio Pharma (BBIO)
NVIDIA Corporation Call Option (NVDA)
Bank of America Corporation (BAC)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Intel Corporation Call Option (INTC)

View all positions for Laurion Capital Management

Top funds holding Urogen Pharma

RA Capital Management
Dr. Jeffrey R. Jay, M.D.
Credit Suisse
Harel Insurance Investments & Financial Services
Migdal Insurance & Financial Holdings
Millennium Management
Opaleye Management
Superstring Capital Management
Laurion Capital Management
Wells Fargo & Company
Citadel Advisors
Vanguard Group
ARK Investment Management
AlphaCentric Advisors
Schonfeld Strategic Advisors

View all funds holding Urogen Pharma